Conclusion: Through rigorous experimental validation, our study demonstrates AS's significant clinical efficacy in managing DN. Specifically, AS has been shown to enhance renal function, ameliorate renal fibrosis, and positively influence iron metabolism. Despite these promising outcomes, future research with a larger sample size must be conducted to further substantiate these findings.
PubMed 40015687 ↗Astragalus
The short answer. There isn't much data on Astragalus yet — 44 mentions, 5 with a clear outcome — so treat these numbers as anecdotal. It is well studied — 122 meta-analyses on PubMed.
From 44 mentions in total — the rest didn't say how it went and aren't counted.
What Astragalus does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 122 meta-analyses on PubMed ↗ · 83 randomized trials ↗
Conclusion: The possible mechanisms of AM are largely through antivirus and antivirus receptors, anti-inflammatory, antioxidation, antiapoptotic, antifibrosis, and reducing cardiac calcium load. In conclusion, the findings suggested that AM is a cardioprotection candidate drug for VM.
PubMed 33204391 ↗Conclusion: AM could improve renal outcomes and alleviate injury through multiple signaling pathways. This indicates AM may be an option to consider for the development of future DKD therapeutics.
PubMed 38733903 ↗Conclusion: In conclusions, adjuvant therapy with CHM-HQ may benefit in managing fatigue and quality of life in stroke patients. However, stronger evidence is needed for a promising conclusion and more rigorous designs of RCTs are merited in the future.
PubMed 31440984 ↗178 human trials on ClinicalTrials.gov test Astragalus — 66 completed, 21 recruiting now. See all on ClinicalTrials.gov ↗
- Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway · Tourette Syndrome in Children · 2026
- Acute Effects of Posterior Talar Glide Mobilization · Ankle Dorsiflexion, Mobilization · 2026
- Clinical Study on the Treatment of Chronic Instability of the Lateral Ankle Joint by Repairing the Anterior Talofibular Ligament Under Total Arthroscopy · Anterior Talofibular Ligament Injury, Ankle Sprains · 2025
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
15 reports name a product containing Astragalus (2005–2025); 6 involved hospitalization or worse. Most often reported:
- Vomiting · 3
- Dyspnoea · 3
- Dizziness · 3
- Hepatic enzyme increased · 3
- Loss of consciousness · 2
- Diarrhoea · 2
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
1 recall of products named for Astragalus. Most recent:
- 2016-05-11 · Class III: Pursuant to a consent decree for injunctive relief the recalling firm was ordered to recall all products because they are misbranded, unapproved new drugs… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
LiverTox rates Astragalus E — an unlikely cause of liver injury. LiverTox entry ↗
“Astragalus may be safe when used orally. (Taking up to 60 grams per day for as long as 4 months does not seem to cause adverse effects.) However, a thorough safety evaluation has not been done.” NCCIH ↗
- Used in Traditional Chinese Medicine (TCM) to tonify the spleen and lungs in cases of qi deficiency with a lack of appetite, fatigue, and diarrhea.
- Used in Traditional Chinese Medicine (TCM) to augment the protective qi and stabilize the exterior in cases of deficiency with spontaneous sweating.
- Used in Herbal Medicine to help maintain a healthy immune system.
- Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress over time (e.g. in case of mental and physical fatigue related to stress).
Required cautions: Ask a health care practitioner before use if you are pregnant or breastfeeding. Ask a health care practitioner before use if you have an autoimmune disorder. Do not use if you have exterior excess, stagnation, yin deficiency or excess heat.
NIH has funded 2 research projects with Astragalus in the title, $55,596 in total (1986–2005). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“as a bodybuilder I take astragalus root for organ support, I did notice slight energy increase from it. I take 3-8 g per day”
“I take astragalus to keep whatever it is at bay and get rid of my fevers.”
“*possibly* Astragalus. Mushroom and astragulus when everyone around me gets sick.”
Top discussions (5)
- How can we best educate people on how to boost their immune systems? People's lives might depend on it in the coming months. ↗
- Thoughts/Feedback On My Supplement/Bio-Hacking Protocol? ↗
- Possibly the best supp stack you'll ever need...or am I just going crazy? Roast me ↗
- all roads lead to dopamine - impulse/addiction/rds - advice ↗
- What reason would there be for ashwagandha to cause anxiety? ↗
Other options for immunity
Sources
- User reports: 44 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- NCCIH (NIH) ↗
- NIH RePORTER ↗
- Health Canada ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate